COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says
Covid-19: Immunocompromised People May Need Fourth Dose, CDC Says Some Americans may require a fourth shot of the COVID-19 vaccine if they are immunocompromised, according to new federal guidance. The Centers for Disease Control and Prevention (CDC), said that adults 18 and older who received the Pfizer or Moderna COVID-19 vaccines and are moderately or severely immunocompromised may get a fourth dose at least six months after getting their third shot, the guidance states. Officials cautioned that Johnson & Johnson recipients “should not receive more than two COVID-19 vaccine doses,” though a second is recommended. The CDC authorized a thir…
COVID-19: FDA Advisory Committee Recommends Vaccines For Kids Ages 5 To 11 COVID-19: FDA Advisory Committee Recommends Vaccines For Kids Ages 5 To 11
Covid-19: FDA Advisory Committee Recommends Vaccines For Kids Ages 5 To 11 A Food and Drug Administration vaccine advisory panel has voted to recommend Pfizer's COVID-19 vaccine for children ages 5 to 11. The endorsement of Pfizer's lower dose vaccine for younger kids was announced on Tuesday, Oct. 26, and it will be considered for authorization by the FDA next. CNBC reported that 17 members of the committee voted to endorse the vaccine, and one person declined to vote. A decision by the FDA could be made within the next few days, CNBC said.  An advisory group with the Centers for Disease Control and Prevention (CDC) is scheduled to meet next week to d…
COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans
Covid-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans The Food and Drug Administration has authorized the use of Johnson & Johnson and Moderna COVID-19 booster shots for millions of people across the United States. The FDA made the announcement on Wednesday afternoon, Oct. 20, nearly a month after the agency authorized the use of a Pfizer COVID-19 booster shot.  The agency said a single booster dose of the Moderna vaccine can be administered at least six months after the two-dose vaccine series is complete in the following groups of people: 65 years of age and older 18 through 64 years of age at high risk of severe COVID-19 18 …
COVID-19: Pfizer Asks FDA To Approve Vaccine For Children Ages 5 To 11 COVID-19: Pfizer Asks FDA To Approve Vaccine For Children Ages 5 To 11
Covid-19: Pfizer Asks FDA To Approve Vaccine For Children Ages 5 To 11 Pfizer has officially asked the US Food and Drug Administration (FDA) for emergency use authorization for its COVID-19 vaccine to be administered to children between the ages of 5 and 11. With parents and politicians alike agreeing that keeping children learning in the classroom after a lost year in 2020, Pfizer is pushing to allow its vaccine to be administered among younger Americans. Pfizer tweeted this week that the company had submitted their formal request for Emergency Use Authorization of the vaccine to the FDA. "With new cases in children in the U.S. continuing to be at a high lev…
COVID-19: Johnson & Johnson To Seek Authorization For Booster Shot COVID-19: Johnson & Johnson To Seek Authorization For Booster Shot
Covid-19: Johnson & Johnson To Seek Authorization For Booster Shot Johnson & Johnson is seeking federal approval for its COVID-19 booster shots, which could make it the latest to be authorized by the US Food and Drug Administration (FDA). On Monday, Oct. 4, a spokesperson for the pharmaceutical company announced that they were looking to gain approval to begin administering booster shots for its one-dose vaccine. Last month, regulators authorized a booster shot for some recipients of the Pfizer vaccine and are considering authorization this month for recipients of the Moderna vaccine. In total, according to reports, more than 15 million Am…
COVID-19: Brand-New Research Reveals Which Vaccine Is Most Effective Over Time COVID-19: Brand-New Research Reveals Which Vaccine Is Most Effective Over Time
Covid-19: Brand-New Research Reveals Which Vaccine Is Most Effective Over Time It turns out not all COVID-19 vaccines are created equal. Newly released research published by the US Centers for Disease Control and Prevention (CDC) has found which federally-authorized COVID vaccine is proving to be most effective over time. The studies that have been published found that Moderna’s vaccine is more effective against the virus months after the vaccination series was completed. According to the CDC, the efficacy of the Pfizer vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. Moderna’s efficac…
COVID-19: School District In Region Considering Vaccine Mandate COVID-19: School District In Region Considering Vaccine Mandate
Covid-19: School District In Region Considering Vaccine Mandate A school district in Western Massachusetts is considering a COVID-19 vaccination mandate to go along with orders to wear facial coverings while in school buildings. Officials in the Amherst-Pelham Regional School District are considering taking the extra step to provide extra protection against the spread of the virus by mandating faculty and staff members all get the COVID-19 vaccine. The decision will now move forward to a special school committee vote. Officials noted that if mandated, particular religious and health exemptions would have to be agreed upon between the school and its se…
COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations
Covid-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations The Centers for Disease Control and Prevention (CDC) has released a new study that found which of the three US-approved COVID-19 vaccines are most effective in preventing hospitalizations, ICU visits, or potential intubation. A recently released study from the CDC determined that the Moderna vaccine was slightly more effective in preventing hospitalizations than the Pfizer or Johnson & Johnson vaccines. In total, approximately 32,000 patients that were treated in hospitals in nine US states were studied by the CDC over the summer and it was determined that the Moderna shot was most effe…
COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations
Covid-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations The Centers for Disease Control and Prevention (CDC) has released a new study that found which of the three US-approved COVID-19 vaccines are most effective in preventing hospitalizations, ICU visits, or potential intubation. A recently released study from the CDC determined that the Moderna vaccine was slightly more effective in preventing hospitalizations than the Pfizer or Johnson & Johnson vaccines. In total, approximately 32,000 patients that were treated in hospitals in nine US states were studied by the CDC over the summer and it was determined that the Moderna shot was most effe…
COVID-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says COVID-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says
Covid-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says The "true delta wave" has not hit the Northeast yet, and it will arrive sometime after Labor Day weekend, former United States Food and Drug Administration Commissioner Dr. Scott Gottlieb said. Gottlieb said in an interview with CNBC on Friday, Sept. 3, that he thinks the jump in delta variant cases in the Northeast that has since decreased was a warning for another spike in cases that will hit the region. He predicted that gatherings during Labor Day weekend and children returning to school will lead to cases increasing once again. Gottlieb recommended that schools increase the frequency …
COVID-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11 COVID-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11
Covid-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11 The Pfizer COVID-19 vaccine could be available to children ages 5 and older late in the fall or early this winter, according to a company board member. Former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb told CNBC that he believes the company's COVID vaccine will be approved for emergency use for children ages 5 to 11 sometime this fall or winter. Gottlieb told the news outlet that the application will likely be submitted to the FDA in October.  He said the FDA will likely take four-to-six weeks to review the application, so the emergency use authorization c…
COVID-19: Unvaccinated Should Not Travel Over Labor Day Weekend, CDC Says COVID-19: Unvaccinated Should Not Travel Over Labor Day Weekend, CDC Says
Covid-19: Unvaccinated Should Not Travel Over Labor Day Weekend, CDC Says The director of the Centers for Disease Control and Prevention (CDC) is recommending that those who are not vaccinated against COVID-19 avoid traveling over the Labor Day weekend. CDC Director Dr. Rochelle Walensky said during a news briefing that those who are fully vaccinated and wearing masks can travel, although she said they should take risks into consideration due to the rate of transmission in the country.  "If you are unvaccinated, we would recommend not traveling,” Walensky said. Walensky also recommended that Americans take precautions during the weekend, such as gathering …